Rhode Island’s legislative session ends with legal

New Post Public Reply Private Reply Replies (0) Message Board
Jerseyfish

Rhode Island’s legislative session ends with legal hemp, licensed medical growers, PTSD added to medical marijuana program; adult-use back next year

Rhode Island is set to join America’s industrial hemp revolution after a legislative vote June 20 to legalize the agriculture.

In final days of its annual session this week, state lawmakers also licensed medical pot growers, and added post-traumatic stress disorder to the state’s medical marijuana program — bolstering support for the sometimes controversial use of medical cannabis. The measures go to Governor Gina Raimondo for approval.

Adult-use legalization was also on the table in the Rhode Island legislature this year, but the session expired this week before The Marijuana Regulation, Control, and Taxation Act was voted on. A recent poll indicates 55 percent of Rhode Islanders said they support regulating marijuana for adults like alcohol.

Under Rhode Island law, hemp will be defined as cannabis containing less than three-tenths of one percent THC, or less. (Medically active cannabis can be up to about 25% THC, cannabis’ main active ingredient.)

The Rhode Island legislature closed up the 2016 legislative session early Saturday morning, after thirteen hours of deliberation.

“Still here @RISenate @ 5:45am from 6/17 in final day of Legislative session. I think we are going for a record,” Senator Juan M. Pichardo tweeted. The state’s Senate and House worked out details of the state’s budget.

Before deadline, lawmakers also tweaked the state’s medical cannabis program to create licensed medical cannabis farmers, and a tag system for the state’s legal pot plants. The tiny state has three dispensaries.

Adult use advocacy group Regulate Rhode Island, along with its coalition, will have to wait until next year’s session. It’s the sixth consecutive year a marijuana legalization bill has failed in America’s smallest state.

Regulate Rhode Island director Jared Moffat says they plan on continuing their efforts to re-introduce a bill next year.
Benjamin M. Adams is a contributor for Cannabis Now Magazine, MerryJane.com, Cannabusiness.com and DirectCannabisNetwork.com. His work has been seen in Culture Magazine, Treating Yourself Magazine, SKUNK Magazine, and several other cannabis-related publications. He studied Art at the University of Utah and has traveled around the world from the open hash markets in Copenhagen to Jamaica. He's focused on the efficacy of medical marijuana for HIV and other serious illnesses. Ben lives in Southern California. You can follow him on Twitter @benbot11.

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading